Pertussigen treatment retards, but fails to prevent, the development of type I, insulin-dependent diabetes mellitus (IDDM) in NOD mice.
Current evidence supports an autoimmune etiopathogenesis for Type I, insulin-dependent diabetes mellitus (IDDM) in which the pancreatic beta (beta) cell is the specific target tissue. Recently, the NOD (non-obese diabetic) mouse has become an important model for IDDM, exhibiting many of the pathological features observed in man, including a progressive pancreatic islet leukocytic inflammation referred to as insulitis. The present study was carried out to determine the efficacy of the bacterial-derived bio-product, pertussigen, to retard the progression of insulitis and thereby prevent overt diabetes. Results revealed that (1) the rapid onset of IDDM in female NOD mice is absent if the mothers are treated with pertussigen prior to mating, (2) treatment of young prediabetic NOD mice with repeated injections of pertussigen results in the retardation of onset of IDDM when compared to untreated control NOD mice, and (3) the severity of insulitis in pertussigen-treated NOD mice not developing IDDM was noticeably less severe than age and sex-matched untreated control mice. Since earlier work had shown that pertussis vaccine, which contains pertussigen, could prevent development of IDDM in mice treated with streptozotocin, the present results may indicate basic differences in the inflammatory responses in the genetically-predisposed NOD mice and IDDM-nonsusceptible mice with streptozotocin-induced diabetes.
Huang
S W
SW
Department of Pediatrics, University of Florida College of Medicine, Gainesville 13210.
Luchetta
R
R
Peck
A B
AB
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000473:pathology / Q000517:prevention & control*; D005260:Female; D007515:Islets of Langerhans / Q000473:pathology; D008297:Male; D008431:Maternal-Fetal Exchange; D051379:Mice; D016688:Mice, Inbred NOD; D010195:Pancreatitis / Q000517:prevention & control; D037342:Pertussis Toxin; D011247:Pregnancy; D010566:Virulence Factors, Bordetella / Q000494:pharmacology* / Q000633:toxicity
D010566:Virulence Factors, Bordetella; D037342:Pertussis Toxin